Vimarsana
Biggest News Aggregation in the World

Page 5 - Phase 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase 3 Today - Breaking & Trending Today

Nominations for Phase 3 of Lok Sabha polls to begin tomorrow: ECI | India News - Vimarsana News

Nominations for Phase 3 of Lok Sabha polls to begin tomorrow: ECI | India News

India News: The filing of nominations for the third phase of the 2024 general elections will begin on Friday, the Election Commission said. "Nominations for the t

Jonathan Silverberg, MD, PhD: New Phase 3 Findings on Nemolizumab for Atopic Dermatitis - Vimarsana News

Jonathan Silverberg, MD, PhD: New Phase 3 Findings on Nemolizumab for Atopic Dermatitis

This interview at AAD featured a discussion with Silverberg on nemolizumab’s efficacy and safety at Week 48 among patients with moderate-to-severe atopic dermatitis.

Sebetralstat Shows Promise, May Become First Oral Acute Treatment for Hereditary Angioedema - Vimarsana News

Sebetralstat Shows Promise, May Become First Oral Acute Treatment for Hereditary Angioedema

The findings in a recent phase 3 clinical study may allow Kalvista Pharma to seek FDA approval for this potential hereditary angioedema treatment option.

Utalii College contractor in race against time ahead of July deadline - Vimarsana News

Utalii College contractor in race against time ahead of July deadline

A spot check at the Ronald Ngara college found machinery on site as workers rush to complete the project.

New TB vaccine that showed hope for South African infants to be tested on teens in 2024 - Vimarsana News

New TB vaccine that showed hope for South African infants to be tested on teens in 2024

A novel TB vaccine candidate that could replace the bacille Calmette-Guerin vaccine and has been found to provide significantly better protection against the TB germ in South African newborns, is set to reach a new benchmark in the new year as it will be tested on teenagers and adults with latent TB.